3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion
We hypothesize that ATTR CM is a microangiopathy driven by capillary bed thrombo-inflammation and dysregulated angiogenic revascularization. Phenotypic convergence of WT ATTR CM and V122I ATTR CM was observed via proteomics, 3D imaging, and ex vivo fibril characterization by cryo-EM. We provide evidence of capillary thrombosis in ex vivo ATTR CM tissue. Vasodilation and increased capillary permeability expose components of the vascular basement membrane (VBM) to misfolded TTR. These components are known to promote TTR aggregation and stabilize amyloid fibrils in the extracellular space. Congestion of the VBM prevents appropriate revascularization, reducing cardiac exertional capacity over time, leading to heart failure. Our ATTR CM heart tissue proteomics data shows significant overlap with the proteomic profiles of human AD brain tissues, revealing key amyloid, coagulation, complement, and angiogenesis proteins being changed in amyloidoses.
Authors
- Karina Nugroho (ORCID: https://orcid.org/0000-0003-1361-993X)
- Zhengyuan Pang (ORCID: https://orcid.org/0000-0003-0321-4891)
- Jan-Hannes Schäfer (ORCID: https://orcid.org/0000-0001-8163-1629)
- Joseph P. Donnelly (ORCID: https://orcid.org/0000-0002-8254-433X)
- Carl T. Ash (ORCID: https://orcid.org/0000-0002-0767-9605)
- Gabriel C. Lander (ORCID: https://orcid.org/0000-0003-4921-1135)
- LI YE
- Marcus Jaeger
- Zi Gao
- Mathew S Maurer
- Evan Powers
- Robert T O'Neill
- Lynee Massey
- Leonard Yoon
- Jeffery W. Kelly
Institutions
- Scripps Research Institute (US)
- Scripps Health (US)
- NewYork–Presbyterian Hospital (US)
- Howard Hughes Medical Institute (US)
- Neurosciences Institute (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-02-11
- DOI
- https://doi.org/10.64898/2026.02.09.704431
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke